Outlook Therapeutics, Inc. (OTLK) vs Spruce Biosciences, Inc. (SPRB)
- Outlook Therapeutics, Inc. OTLK 0.49 −2.00%
- Spruce Biosciences, Inc. SPRB 39.65 −4.39%
Outlook Therapeutics, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. Outlook Therapeutics, Inc. and Spruce Biosciences, Inc. are of similar size ($121.7M and $119.2M). Spruce Biosciences, Inc. grew revenue faster over the last twelve months: −51.3% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Outlook Therapeutics, Inc. leads on 9 and Spruce Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | OTLK | SPRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 195.62% | 100.00% | 65.16% |
| Operating margin | 4,781.76% | 0.00% | 0.00% |
| Net margin | 5,253.40% | 0.00% | 0.00% |
| Free cash flow margin | 4,826.38% | 0.00% | 0.00% |
| Return on equity | 256.92% | (105.98%) | (56.36%) |
| Return on assets | (251.66%) | (82.38%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack